A prospective clinical trial in melanoma patients with bone involvement addressing immunological effects of the RANKL-inhibitor denosumab in combination with dual checkpoint inhibition
EXPERIMENTAL DERMATOLOGY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要